FDA Investigating Safety of Asthma Drug Xolair
Links shared publicly online about this topic.
- 1,893total visits
FDA Investigating Safety of Asthma Drug Xolair
View full resource at health.msn.com
Tags: Asthma, Asthma Medication, Drug, FDA, Xolair
Most Recently Shared on July 16, 2009 at 8:32 pm By:
FDA Investigating Safety of Asthma Drug Xolair http://bit.ly/3KRh8
Asthma drug Xolair fails to gain support from FDA panel - Related Stories - AAP SmartBrief
smartbrief.com — “Roche Holding and Novartis failed to obtain FDA panel support for using their asthma drug Xolair in patients ages 6 to 11. Although Xolair would be useful in some children, experts said, there is still concern about the drug's safety and its possible link to an increased risk of cancer. <a href='/se” View full resource at smartbrief.com
Most Recently Shared on November 20, 2009 at 2:12 am By:
Clara Song Doctor, Pediatrician, and Physician
Asthma drug Xolair fails to gain support from FDA panel http://sbne.ws/r/3jfD
UPDATE 3-U.S. panel rejects Xolair asthma drug for children | Reuters
reuters.com — “* FDA advisory panel votes 10-4 against approval of Xolair * Experts concerned over safety; split on efficacy * Move means Xolair may stay restricted to over-12s (Adds comment from companies) By” View full resource at reuters.com
Most Recently Shared on November 18, 2009 at 11:27 pm By:
Ben Hirschler Health Communicator
My first FDA panel - quite exciting in end, what with split among experts and faulty electronic voting system http://tinyurl.com/yfwxs5r
Asthma Drug Xolair Is Being Investigated By FDA For Possible Cardiac Problems - Drug Injury Watch
drug-injury.com — “Serious Side Effects Include Heart Attacks, Abnormal Heart Rhythms, Heart Failure, And Various Conditions Caused By Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) By means of a July 16, 2009 MedWatch Email Alert we first learned about an ongoing FDA investigation of Xolair (omalizumab): FDA is evaluating interim safety findings from an ongoing study of Xolair (omalizumab) titled Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS” View full resource at drug-injury.com
Most Recently Shared on September 23, 2009 at 12:28 am By:
Frederick Schurger, DC Chiropractor, Doctor, and CAM
Asthma Drug Xolair Is Being Investigated By FDA For Possible Cardiac Problems http://bit.ly/C1DPq
FDA Investigating Safety of Asthma Drug Xolair - Asthma Symptoms, Relief Therapies, Treatment and Medications on MedicineNet.com
medicinenet.com — “Medical information about asthma symptoms and relief therapies: doctor produced and written for patients experiencing asthma related conditions to make informed health decisions.” View full resource at medicinenet.com
Most Recently Shared on July 18, 2009 at 7:43 am By:
MedicineNet: FDA Investigating Safety of Asthma Drug Xolair http://tinyurl.com/lzkkyz Full http://tinyurl.com/ldyd3m
FDA scrutinizing safety of asthma drug Xolair - CNN.com
cnn.com — “The Food and Drug Administration announced Thursday it is conducting a safety review of the asthma drug Xolair after data from an ongoing study suggested an increased number of heart attacks and strokes among patients who use it.” View full resource at cnn.com
Most Recently Shared on July 17, 2009 at 9:14 pm By:
Dr. Seung-Jun O, MD Doctor, Surgeon, Plastic Surgeon, and Physician
Health News FDA scrutinizing safety of asthma drug Xolair: The Food and Drug Administration announced.. http://bit.ly/NBOYP
FDA Investigating Safety of Asthma Drug Xolair - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration has begun a safety review of the asthma drug Xolair (omalizumab) after reports of an increased risk of heart attack, abnor” View full resource at drugs.com
Most Recently Shared on July 17, 2009 at 5:48 am By:
FDA Investigating Safety of Asthma Drug Xolair - http://bit.ly/qQ3HS
Medical News: Cardiovascular Events in Omalizumab Trial Prompt FDA Scrutiny - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA is reviewing safety data from an ongoing trial of the asthma drug omalizumab (Xolair) after interim results showed an excess of cardiovascular and cerebrovascular events among p” View full resource at medpagetoday.com
Most Recently Shared on July 17, 2009 at 12:57 am By:
Cardiovascular Events in Omalizumab Trial Prompt FDA Scrutiny http://ow.ly/15HYtf
FDA investigating link between asthma drug and heart attack, stroke risk | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “An ongoing clinical trial of the asthma drug Xolair suggests that patients taking the medication may have an increased risk of blood clots, heart failure, stroke, cardiac arrhythmias and heart enlargement when compared to patients not treated with the asthma...” View full resource at latimesblogs.latimes.com
Most Recently Shared on July 16, 2009 at 10:45 pm By:
LA Times Health News Health News
FDA investigating link between asthma drug and heart attack, stroke risk http://bit.ly/XFFvS
Advertisement
